The hychlo™ technology developed by Aquilabs represents the achievement of a necessary balance between the safety and efficacy of hypochlorous acid solutions. This novel, stabilized chemical technology offers rapid broad-spectrum antimicrobial activity, without the adverse effects that can compromise quality or irritate the skin and respiratory systems.
The Aquilabs technology is clearly differentiated from other methods to which have been used to access the therapeutic benefit of hypochlorous acid, one of the amazing products obtained from Hychlo™ technology is HychloHSD™.
HychloHSD™ (Healthcare) is a hypochlorous acid based solution at 0.33% with a wide spectrum and fast action.
This product sanitizes and disinfects hard non-porous surfaces in healthcare facilities, hospitals, walk in clinics, medical and dental offices as well as clinical laboratories and biomedical research labs.
Benefits of HychloHSD™ (Healthcare):
*Test made with all GLP regulations. HychloHSD for healthcare facilities, at use concentration when tested against contaminants and pathogens and even in presence of high organic loads, showed a bacterial kill rate of 99.999% – 6 log reduction
** Established LD50 > 5000 mg/kg in animal testing on wistar rats and New Zealand rabbits over 14 days. Solution tested at 5000, 2500, and 1250 mg/kg. All research performed according to the Good Laboratory Practices and consistent with the evaluation of toxic substances established by the U.S. Environmental Protection Agency (EPA) notifications 40 CRF, part 160, and 792 of the E.U. Organization for Economic Cooperation and Development (OECD) “Quality Assurance and GLP” guide.